Nicola Salvatore Orefice

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis

Nicola Salvatore Orefice, Mireille Alhouayek, Antonio Carotenuto et al. · Neurotherapeutics · 2016 · 59 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice

Benoît Souchet, Mickaël Audrain, Jean Marie Billard et al. · Acta Neuropathologica Communications · 2019 · 49 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain

Nicola Salvatore Orefice, Benoît Souchet, Jérôme Braudeau et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 45 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress

Giuseppina Mattace Raso, Raffaele Simeoli, Roberto Russo et al. · Pharmacological Research · 2013 · 40 citations

Medicine, Nephrology, Pharmacology +15

Increased expression of SLC25A1/CIC causes an autistic-like phenotype with altered neuron morphology

Michael J. Rigby, Nicola Salvatore Orefice, Alexis J. Lawton et al. · Brain · 2021 · 24 citations · Full text

Life Sciences, Neuroscience, Neurobiology Of Disease +9